|
Publications (1999-2009)
1: Santourlidis S, Graffmann N, Christ J, Uhrberg M. Lineage-specific transition of
histone signatures in the killer cell Ig-like receptor locus from hematopoietic
progenitor to NK cells. J Immunol 2008.
2: Edgar Grinstein, Yihua Du, Simeon Santourlidis, Julia christ, Markus Uhrberg and
Peter Wernet. Nucleolin regulating gene expression in CD34 positive
hematopoietic cells. J Biol Chem 2007.
3: Graffmann N, Santourlidis S, Christ J, Wernet P, Uhrberg M. Direct and quantitative
analysis of chromatin accessibility by MIRECAL--a Micrococcus nuclease/real-
time PCR chromatin accessibility assay with locus specificity. Anal Biochem
2006
4: Trundley AE, Hiby SE, Chang C, Sharkey AM, Santourlidis S, Uhrberg M, Trowsdale
J, Moffett A. Molecular characterization of KIR3DL3. Immunogenetics 2006.
5: Hans-Ingo Trompeter, Natalia Gomez-Lozano, Simeon Santourlidis, Britta Eisermann,
Peter Wernet, Carlos Vilches, and Markus Uhrberg. Three Structurally and
Functionally Divergent Kinds of Promoters Regulate Expression of Clonally
Distributed Killer Cell Ig-Like Receptors (KIR), of KIR2DL4, and of KIR3DL3. J
Immunol 2005.
6: Santourlidis S, Kimura F, Fischer J, Schulz WA. Suppression of clonogenicity by
mammalian Dnmt1 mediated by the PCNA-binding domain. Biochem Cell Biol
2004
7: Stallmach A, Wittig BM, Kremp K, Goebel R, Santourlidis S, Zeitz M, Menges M,
Raedle J, Zeuzem S, Schulz WA. Downregulation of CD44v6 in colorectal
carcinomas is associated with hypermethylation of the CD44 promoter region.
Exp Mol Pathol 2003.
8: Kimura F, Seifert HH, Florl AR, Santourlidis S, Steinhoff C, Swiatkowski S, Mahotka
C,Gerharz CD, Schulz WA. Decrease of DNA methyltransferase 1 expression
relative to cell proliferation in transitional cell carcinoma. Int J Cancer 2003.
9: Santourlidis S, Trompeter HI, Weinhold S, Eisermann B, Meyer KL, Wernet P,
Uhrberg M. Crucial role of DNA methylation in determination of clonally
distributed killer cell Ig-like receptor expression patterns in NK cells. J Immunol
2002
10: Schulz WA, Elo JP, Florl AR, Pennanen S, Santourlidis S, Engers R, Buchardt M,
Seifert HH, Visakorpi T. Genomewide DNA hypomethylation is associated with
alterations on chromosome 8 in prostate carcinoma. Genes Chromosomes
Cancer 2002.
11: Leube B, Drechsler M, Muhlmann K, Schafer R, Schulz WA, Santourlidis S,
Anastasiadis A, Ackermann R, Visakorpi T, Muller W, Royer-Pokora B. Refined
mapping of allele loss at chromosome 10q23-26 in prostate cancer. Prostate
2002
12: Santourlidis S, Warskulat U, Florl AR, Maas S, Pulte T, Fischer J, Muller W, Schulz
WA. Hypermethylation of the tumor necrosis factor receptor superfamily 6
(APT1, Fas, CD95/Apo-1)gene promoter at rel/nuclear factor kappaB sites in
prostatic carcinoma. Mol Carcinog 2001.
13: Santourlidis S, Florl A, Ackermann R, Wirtz HC, Schulz WA. High frequency of
alterations in DNA methylation in adenocarcinoma of the prostate. Prostate
1999
14: Aguiar J, Santurlidis S, Nowok J, Alexander C, Rudnicki D, Gispert S, Schulz W,
Auburger G. Identification of the physiological promoter for spinocerebellar
ataxia 2 gene reveals a CpG island for promoter activity situated into the exon 1
of this gene and provides data about the origin of the nonmethylated state of
these types of islands. Biochem Biophys Res Commun 1999.
|
